Daily Health Headlines

Regular Mammograms Worthwhile for Elderly Women

👤by HealthDay 0 comments 🕔Friday, January 8th, 2016

THURSDAY, Jan. 7, 2016 (HealthDay News) -- Regular mammograms benefit elderly women, a new study indicates.

Previous research has shown that mammography screening reduces breast cancer deaths among women up to age 74, but there is little information about women older than 74, especially minority women, the Florida Atlantic University researchers explained.

They analyzed Medicare data from 1995 to 2009 on more than 4,800 black women and more than 59,000 white women, all of whom were aged 69 or older.

Among women aged 75 to 84, those who had annual mammograms were less likely to die from breast cancer over a 10-year period than those who had irregular or no mammograms.

Breast cancer patients aged 69 to 84 who had annual mammograms in the four years before their diagnosis had lower five- and 10-year death rates than those who had irregular or no mammograms.

Ten-year death rates among women aged 69 to 84 were three times higher among whites and more than two times higher among blacks who had irregular or no mammogram screening, compared with those who had annual mammograms.

The researchers also found that white women who died of breast cancer were more likely to be older, to have been diagnosed at a later stage and to have received chemotherapy. They were also less likely to have had surgery or have undergone radiation therapy.

The study was published Jan. 6 in the American Journal of Medicine.

Breast cancer is the second most common type of cancer in American women, affecting one in eight during their lifetime and killing one in 25. In 2010, 41 percent of breast cancer deaths occurred in women aged 65 to 84.

Regular mammography is recommended for women aged 65 to 74, according to the American Cancer Society and the U.S. Preventive Services Task Force.

-- Robert Preidt

Article Credits / Source

HealthDay

HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: Florida Atlantic University, news release, Jan. 6, 2016

View More Articles From HealthDay 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Cancer Articles

No Benefit From Routine Thyroid Cancer Screening: Task Force

No Benefit From Routine Thyroid Cancer Screening: Task Force0

TUESDAY, Nov. 22, 2016 (HealthDay News) -- Doctors should not screen for thyroid cancer in patients who have no symptoms of the disease, according to a U.S. Preventive Services Task Force draft recommendation. It reaffirms a recommendation ...

Depressed Women Less Likely to Get Best Breast Cancer Care: Study

Depressed Women Less Likely to Get Best Breast Cancer Care: Study0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Breast cancer patients with a history of depression are less likely to receive recommended care for their disease, a new study finds. The study included more than 45,000 Danish women diagnosed with ...

Earnings Fall After a Child's Cancer Diagnosis

Earnings Fall After a Child's Cancer Diagnosis0

MONDAY, Nov. 21, 2016 (HealthDay News) -- After a child's cancer diagnosis, parents' income often drops and mothers frequently stop working, a new study finds. Moreover, the financial effects of a cancer diagnosis can last years, with mothers' ...

Monoclonal Antibodies

Monoclonal Antibodies0

home / cancer center / cancer a-z list / monoclonal antibodies index / monoclonal antibodies drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his ...

New Drug May Brighten Outlook for Advanced Breast Cancer

New Drug May Brighten Outlook for Advanced Breast Cancer0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms. The drug, called palbociclib (Ibrance), was approved in the United States last year ...

View More Cancer Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!